<unk> , sold under the brand name Breztri Aerosphere among others, is an inhalable fixed-dose combination medication for the treatment of chronic obstructive pulmonary disease (COPD). It contains<unk> ,<unk>  bromide, and formoterol fumarate dihydrate. It is inhaled. The most common side effects include oral candidiasis (a fungal infection of the mouth), upper respiratory tract infection, pneumonia, back pain, muscle spasms, influenza, urinary tract infection, cough, sinusitis and diarrhea. The combination was approved for medical use in the United States in July 2020, and in the European Union in December 2020.
Budesonide/glycopyrronium bromide/formoterol
Beclometasone/formoterol/glycopyrronium bromide
Budesonide/formoterol
Fluticasone furoate/umeclidinium bromide/vilanterol
Glycopyrronium bromide/formoterol
Aclidinium bromide/formoterol
Ipratropium bromide/salbutamol
Mometasone/formoterol